Gentry Private Wealth’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$478K Sell
3,719
-173
-4% -$20.2K 0.25% 52
2026
Q1
$468K Sell
3,892
-433
-10% -$50K 0.28% 54
2025
Q4
$455K Sell
4,325
-847
-16% -$79.5K 0.29% 53
2025
Q3
$434K Buy
5,172
+254
+5% +$20.9K 0.3% 62
2025
Q2
$389K Buy
4,918
+68
+1% +$5.41K 0.3% 67
2025
Q1
$435K Buy
+4,850
New +$453K 0.36% 64
2024
Q4
Sell
-3,069
Closed -$349K 61
2024
Q3
$349K Buy
3,069
+8
+0.3% +$950 0.28% 65
2024
Q2
$379K Buy
+3,061
New +$394K 0.33% 54

Other funds holding MRK

Gentry Private Wealth's MRK Position: Q2 2026 in Review

Gentry Private Wealth reduced its Merck (MRK) stake by 4.4% in Q2 2026, selling an estimated $20.2K and leaving 3,719 shares worth $478K. The position accounts for 0.25% of the portfolio, ranked #52.

Gentry Private Wealth first reported a position in MRK in Q2 2024 and has held it in 8 quarters since. 3,841 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Gentry Private Wealth held 3,719 shares of Merck worth $478K as of Q2 2026.
  • Gentry Private Wealth sold 173 Merck shares in Q2 2026, an estimated $20.2K.
  • Merck made up 0.25% of Gentry Private Wealth's portfolio in Q2 2026, its #52 holding.
  • Gentry Private Wealth first reported a position in Merck in Q2 2024 and has held it in 8 quarters since.
  • 3,841 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Gentry Private Wealth's 13F filing for Q2 2026, filed 5 Aug 2026.